-+ 0.00%
-+ 0.00%
-+ 0.00%

Aptevo wins $1.5 million CARE Fund grant for APVO451 IND-enabling work

PUBT·08/14/2026 12:10:55
Listen to the news
Aptevo wins $1.5 million CARE Fund grant for APVO451 IND-enabling work
  • Aptevo secured a USD 1.5 million non-dilutive CARE Fund grant to support IND-enabling work for solid-tumor candidate APVO451.
  • Funding targets development-candidate selection by year-end 2026; IND-enabling studies planned for 1Q27.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-350537), on August 14, 2026, and is solely responsible for the information contained therein.